Literature DB >> 6143505

Hemodynamic effects of sublingual nifedipine in acute myocardial infarction.

G D Gordon, T A Mabin, S Isaacs, E A Lloyd, H G Eichler, L H Opie.   

Abstract

Twenty-six patients with acute myocardial infarction (mean delay time 6 hours after onset of symptoms) were randomized to control or nifedipine treatment (10 mg sublingually, followed by 10 mg every 6 hours for a total of 24 hours). Nifedipine reduced arterial blood pressure from 127/78 to 115/70 mm Hg at 30 minutes (p less than 0.001) and continued to reduce the blood pressure significantly for 12 to 18 hours. Nifedipine also reduced systemic vascular resistance and the rate-pressure product. Cardiac output increased from 4.9 liters/min before nifedipine to 5.4 liters/min at 60 minutes (p less than 0.05 vs controls). In patients with high initial pulmonary wedge pressures, sublingual nifedipine decreased the wedge pressure (p less than 0.001) more effectively than did 80 mg of furosemide given intravenously. Thus, nifedipine may be useful in patients with early myocardial infarction and left ventricular failure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143505     DOI: 10.1016/0002-9149(84)90069-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction.

Authors:  J Wilson; P J Commerford; R S Millar; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

Review 2.  Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

Review 3.  Protective effects of calcium antagonists against ischaemia and reperfusion damage.

Authors:  R Ferrari; O Visioli
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

Authors:  P H Held; S Yusuf; C D Furberg
Journal:  BMJ       Date:  1989-11-11

5.  Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction.

Authors:  L J Walker; G MacKenzie; A A Adgey
Journal:  Br Heart J       Date:  1988-04

6.  The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction.

Authors:  R C de Nooijer; E E van der Wall; V M Cats; G van Herpen; A van der Laarse; J A Blokland; W Jaarsma; J W Arndt; A V Bruschke
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

Review 7.  Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

Review 8.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.